CN102138991B - Pharmaceutical composition for treating oral cancer and skin cancer - Google Patents
Pharmaceutical composition for treating oral cancer and skin cancer Download PDFInfo
- Publication number
- CN102138991B CN102138991B CN2011100882817A CN201110088281A CN102138991B CN 102138991 B CN102138991 B CN 102138991B CN 2011100882817 A CN2011100882817 A CN 2011100882817A CN 201110088281 A CN201110088281 A CN 201110088281A CN 102138991 B CN102138991 B CN 102138991B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- pharmaceutical composition
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000000849 skin cancer Diseases 0.000 title claims abstract description 23
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 18
- 208000003445 Mouth Neoplasms Diseases 0.000 title claims abstract description 17
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 title claims abstract description 17
- 208000000453 Skin Neoplasms Diseases 0.000 title abstract description 9
- 210000000582 semen Anatomy 0.000 claims abstract description 35
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 16
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 16
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241001312741 Gekko swinhonis Species 0.000 claims description 26
- 241001094455 Cipangopaludina chinensis Species 0.000 claims description 15
- 241000217407 Margaritifera Species 0.000 claims description 15
- 241001057584 Myrrha Species 0.000 claims description 15
- 241000131808 Scolopendra Species 0.000 claims description 15
- 201000008261 skin carcinoma Diseases 0.000 claims description 14
- 241000533849 Gleditsia Species 0.000 claims description 9
- 235000009815 Momordica Nutrition 0.000 claims description 9
- 241000218984 Momordica Species 0.000 claims description 9
- 241000545442 Radix Species 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 6
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 240000003146 Lobelia chinensis Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000014220 Rhus chinensis Nutrition 0.000 abstract 1
- 240000003152 Rhus chinensis Species 0.000 abstract 1
- 241000270295 Serpentes Species 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 235000019270 ammonium chloride Nutrition 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 229940079593 drug Drugs 0.000 description 14
- 238000005242 forging Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 201000005443 oral cavity cancer Diseases 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a pharmaceutical composition for treating oral cancer and skin cancer, comprising the following active components in parts by weight: 180-220 parts of semen momordicae (fried), 45-55 parts of barbat skullcap, 45-55 parts of Chinese lobelia, 90-110 parts of rhubarb, 45-55 parts of oldenlandia diffusa, 90-110 parts of radix euphorbiae lantu, 18-22 parts of notoginseng, 27-33 parts of spina gleditsiae, 90-110 parts of nux vomica (fried), 45-55 parts of wild ginger, 45-55 parts of wistaria, 45-55 parts of myrrh, 90-110 parts of rhus chinensis mill, 45-55 parts of dried alum, 18-22 parts of sal ammoniac, 27-33 parts of dragon bone (calcined) 18-22 parts of gecko, 8-12 parts of black-tail snake, 27-33 parts of centipede, 18-22 parts of mother of pearl and 18-22 parts of paludine. Compared with the prior art, the pharmaceutical composition for treating oral cancer and skin cancer has the advantages of quick effect taking speed, high efficiency, high cure rate, no side effect and low treatment cost.
Description
Technical field
The present invention relates to the medical medicine technical field, particularly relate to a kind of pharmaceutical composition that is used for the treatment of cancer.
Background technology
At present, the medicine for the treatment of oral cavity, skin cancer is many, hemoporphyrin, XIAOAIPING PIAN, cinobufacin sheet etc.Conventional method mainly contains operation and cuts off technology and radio-frequency ablation technique.The treatment time of these medicines and method is long, and cure rate is low, and therapeutic effect is poor, and economic cost is high, brings great spirit and financial burden to the patient.
Summary of the invention
The objective of the invention is to overcome the problem that existing treatment technology and medicine exist, provide a kind of treat oral cavity, skin cancer rapidly and efficiently, cure rate is high, have no side effect, pharmaceutical composition that treatment cost is low.
The object of the present invention is achieved like this: a kind of pharmaceutical composition for the treatment of oral cancer, skin carcinoma, active component by following weight portion forms: Semen Momordicae (stir-fry) 180-220 part, Herba Scutellariae Barbatae 45-55 part, Herba Lobeliae Chinensis 45-55 part, Radix Et Rhizoma Rhei 90-110 part, Herba Hedyotidis Diffusae 45-55 part, Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 90-110 part, Radix Notoginseng 18-22 part, Spina Gleditsiae 27-33 part; Semen Strychni (stir-fry) 90-110 part, Herba Asari 45-55 part, Caulis wisteriae sinensis 45-55 part, Myrrha 45-55 part, Galla Chinensis 90-110 part; Dried Alumen 45-55 part, Sal Ammoniacus 18-22 part, Os Draconis (forging) 27-33 part; Gekko Swinhonis (referring to Gekko Swinhonis) 18-22 part, Zaocys 8-12 part, Scolopendra 27-33 part, Concha Margaritifera 18-22 part, Cipangopaludina chinensis 18-22 part.
In a preferred embodiment, the pharmaceutical composition for the treatment of oral cancer of the present invention, skin carcinoma, active component by following weight portion forms: 200 parts of Semen Momordicaes (stir-fry), 50 parts of Herba Scutellariae Barbataes, 50 parts of Herba Lobeliae Chinensis, 100 parts of Radix Et Rhizoma Rhei, 50 parts of Herba Hedyotidis Diffusaes, 100 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 20 parts of Radix Notoginseng, 30 parts of Spina Gleditsiaes; 100 parts of Semen Strychni (stir-fry), 50 parts of Herba Asaris, 50 parts, Caulis wisteriae sinensis, 50 parts of Myrrhas, 100 parts of Galla Chinensiss; 50 parts of dried Alumens, 20 parts of Sal Ammoniacuss, 30 parts of Os Draconis (forging); 20 parts of Gekko Swinhoniss (referring to Gekko Swinhonis), 10 parts of Zaocyss, 30 parts of Scolopendras, 20 parts of Concha Margaritiferas, 20 parts of Cipangopaludina chinensiss.
In another preferred embodiment, the pharmaceutical composition for the treatment of oral cancer of the present invention, skin carcinoma, active component by following weight portion forms: 180 parts of Semen Momordicaes (stir-fry), 46 parts of Herba Scutellariae Barbataes, 45 parts of Herba Lobeliae Chinensis, 90 parts of Radix Et Rhizoma Rhei, 45 parts of Herba Hedyotidis Diffusaes, 91 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 18 parts of Radix Notoginseng, 27 parts of Spina Gleditsiaes; 90 parts of Semen Strychni (stir-fry), 45 parts of Herba Asaris, 45 parts, Caulis wisteriae sinensis, 45 parts of Myrrhas, 90 parts of Galla Chinensiss; 45 parts of dried Alumens, 18 parts of Sal Ammoniacuss, 27 parts of Os Draconis; 18 parts of Gekko Swinhoniss (referring to Gekko Swinhonis), 8 parts of Zaocyss, 27 parts of Scolopendras, 18 parts of Concha Margaritiferas, 18 parts of Cipangopaludina chinensiss.
In another preferred embodiment, the pharmaceutical composition for the treatment of oral cancer of the present invention, skin carcinoma, it is characterized in that: the active component by following weight portion forms: 220 parts of Semen Momordicaes (stir-fry), 54 parts of Herba Scutellariae Barbataes, 55 parts of Herba Lobeliae Chinensis, 110 parts of Radix Et Rhizoma Rhei, 54 parts of Herba Hedyotidis Diffusaes, 110 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 22 parts of Radix Notoginseng, 33 parts of Spina Gleditsiaes; 110 parts of Semen Strychni (stir-fry), 55 parts of Herba Asaris, 55 parts, Caulis wisteriae sinensis, 55 parts of Myrrhas, 110 parts of Galla Chinensiss; 55 parts of dried Alumens, 22 parts of Sal Ammoniacuss, 33 parts of Os Draconis (forging); 22 parts of Gekko Swinhoniss (referring to Gekko Swinhonis), 12 parts of Zaocyss, 33 parts of Scolopendras, 22 parts of Concha Margaritiferas, 22 parts of Cipangopaludina chinensiss.
The pharmaceutical composition of above-mentioned arbitrary described treatment oral cancer, skin carcinoma, it is injection, unguentum or powder.
The preparation method that above-mentioned each Chinese medicinal components is prepared into compound preparation of the present invention is:
Take the above-mentioned Chinese medicine crude drug of recipe quantity; first Semen Momordicae, Semen Strychni are fried to yellowish-brown with pot; mix with Herba Scutellariae Barbatae, Herba Lobeliae Chinensis, Radix Et Rhizoma Rhei, Herba Hedyotidis Diffusae, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Radix Notoginseng, Spina Gleditsiae, Semen Strychni, Herba Asari, Caulis wisteriae sinensis, Galla Chinensis; after adding 3 times of water gagings; boiled with vigorous fire, then burnt 3 hours with slow fire, add Myrrha after truce; be cooled to 40 degree, filter.Dried Alumen, Sal Ammoniacus, Os Draconis (forging), Gekko Swinhonis (referring to Gekko Swinhonis), Zaocys, Scolopendra, Concha Margaritifera, Cipangopaludina chinensis are mixed with above-mentioned gained medicinal liquid, add 2 times of water gagings and fried in shallow oil 3 hours, filter.Filtering residue adds 4 times of water gagings to be fried in shallow oil 2 hours, filtered.Twice filtrate merges, and places sedimentation more than 12 hours, gets supernatant and is evaporated to extractum below 60 ℃ and contains crude drug 2g/ml.Extractum is put in stainless steel disc, and vacuum drying (below 60 ℃) claims dried cream (extractum rate approximately 15%) to pulverize, and adds appropriate excipient, such as cane sugar powder, makes 40 order dissolved granulies and packing.Every bag 10g, taking after mixing it with water with the 150ml boiled water gets final product.
Usage and dosage: each serving 1 bag, take every day 2 times.
The present invention has advantages of following beneficial effect and significant progressive: rapidly and efficiently, cure rate is high, have no side effect, treatment cost is low.
The specific embodiment
Be below specific embodiments of the invention, technical scheme of the present invention is done further the description, but protection scope of the present invention is not limited to these embodiment.Every do not deviate from the change of the present invention design or be equal to substitute include within protection scope of the present invention.
The preparation of the pharmaceutical composition of embodiment 1 treatment oral cancer, skin carcinoma
Crude drug prescription: 190 parts of Semen Momordicaes (stir-fry), 48 parts of Herba Scutellariae Barbataes, 46 parts of Herba Lobeliae Chinensis, 98 parts of Radix Et Rhizoma Rhei, 50 parts of Herba Hedyotidis Diffusaes, 100 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 20 parts of Radix Notoginseng, 30 parts of Spina Gleditsiaes; 100 parts of Semen Strychni (stir-fry), 50 parts of Herba Asaris, 50 parts, Caulis wisteriae sinensis, 50 parts of Myrrhas, 100 parts of Galla Chinensiss; 50 parts of dried Alumens, 20 parts of Sal Ammoniacuss, 30 parts of Os Draconis (forging); 20 parts of Gekko Swinhoniss (referring to Gekko Swinhonis), 10 parts of Zaocyss, 30 parts of Scolopendras, 20 parts of Concha Margaritiferas, 20 parts of Cipangopaludina chinensiss.
Preparation method: the above-mentioned Chinese medicine crude drug that takes recipe quantity; first Semen Momordicae, Semen Strychni are fried to yellowish-brown with pot; mix with Herba Scutellariae Barbatae, Herba Lobeliae Chinensis, Radix Et Rhizoma Rhei, Herba Hedyotidis Diffusae, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Radix Notoginseng, Spina Gleditsiae, Semen Strychni, Herba Asari, Caulis wisteriae sinensis, Galla Chinensis; after adding 3 times of water gagings; boiled with vigorous fire, then burnt 3 hours with slow fire, add Myrrha after truce; be cooled to 40 degree, filter.Dried Alumen, Sal Ammoniacus, Os Draconis (forging), Gekko Swinhonis (referring to Gekko Swinhonis), Zaocys, Scolopendra, Concha Margaritifera, Cipangopaludina chinensis are mixed with above-mentioned gained medicinal liquid, add 2 times of water gagings and fried in shallow oil 3 hours, filter.Filtering residue adds 4 times of water gagings to be fried in shallow oil 2 hours, filtered.Twice filtrate merges, and places sedimentation more than 12 hours, gets supernatant and is evaporated to extractum below 60 ℃ and contains crude drug 2g/ml.Extractum is put in stainless steel disc, and vacuum drying (below 60 ℃) claims dried cream (extractum rate approximately 15%) to pulverize, and adds appropriate cane sugar powder, makes 40 order dissolved granulies and packing, every bag 10g.
The preparation of the pharmaceutical composition of embodiment 2 treatment oral cancer, skin carcinoma
Crude drug prescription: 180 parts of Semen Momordicaes (stir-fry), 46 parts of Herba Scutellariae Barbataes, 45 parts of Herba Lobeliae Chinensis, 90 parts of Radix Et Rhizoma Rhei, 45 parts of Herba Hedyotidis Diffusaes, 91 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 18 parts of Radix Notoginseng, 27 parts of Spina Gleditsiaes; 90 parts of Semen Strychni (stir-fry), 45 parts of Herba Asaris, 45 parts, Caulis wisteriae sinensis, 45 parts of Myrrhas, 90 parts of Galla Chinensiss; 45 parts of dried Alumens, 18 parts of Sal Ammoniacuss, 27 parts of Os Draconis; 18 parts of Gekko Swinhoniss (referring to Gekko Swinhonis), 8 parts of Zaocyss, 27 parts of Scolopendras, 18 parts of Concha Margaritiferas, 18 parts of Cipangopaludina chinensiss.
Preparation method: the above-mentioned Chinese medicine crude drug that takes recipe quantity; first Semen Momordicae, Semen Strychni are fried to yellowish-brown with pot; mix with Herba Scutellariae Barbatae, Herba Lobeliae Chinensis, Radix Et Rhizoma Rhei, Herba Hedyotidis Diffusae, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Radix Notoginseng, Spina Gleditsiae, Semen Strychni, Herba Asari, Caulis wisteriae sinensis, Galla Chinensis; after adding 3 times of water gagings; boiled with vigorous fire, then burnt 3 hours with slow fire, add Myrrha after truce; be cooled to 40 degree, filter.Dried Alumen, Sal Ammoniacus, Os Draconis (forging), Gekko Swinhonis (referring to Gekko Swinhonis), Zaocys, Scolopendra, Concha Margaritifera, Cipangopaludina chinensis are mixed with above-mentioned gained medicinal liquid, add 2 times of water gagings and fried in shallow oil 3 hours, filter.Filtering residue adds 4 times of water gagings to be fried in shallow oil 2 hours, filtered.Twice filtrate merges, and places sedimentation more than 12 hours, gets supernatant and is evaporated to extractum below 60 ℃ and contains crude drug 2g/ml.Extractum is put in stainless steel disc, and vacuum drying (below 60 ℃) claims dried cream (extractum rate approximately 15%) to pulverize, and adds appropriate cane sugar powder, makes 40 order dissolved granulies and packing, every bag 10g.
The preparation of the pharmaceutical composition of embodiment 3 treatment oral cancer, skin carcinoma
Crude drug prescription: 210 parts of Semen Momordicaes (stir-fry), 54 parts of Herba Scutellariae Barbataes, 53 parts of Herba Lobeliae Chinensis, 108 parts of Radix Et Rhizoma Rhei, 54 parts of Herba Hedyotidis Diffusaes, 110 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 21 parts of Radix Notoginseng, 33 parts of Spina Gleditsiaes; 107 parts of Semen Strychni (stir-fry), 55 parts of Herba Asaris, 55 parts, Caulis wisteriae sinensis, 55 parts of Myrrhas, 110 parts of Galla Chinensiss; 55 parts of dried Alumens, 22 parts of Sal Ammoniacuss, 33 parts of Os Draconis (forging); 22 parts of Gekko Swinhoniss (referring to Gekko Swinhonis), 12 parts of Zaocyss, 33 parts of Scolopendras, 22 parts of Concha Margaritiferas, 22 parts of Cipangopaludina chinensiss.
Preparation method: the above-mentioned Chinese medicine crude drug that takes recipe quantity; first Semen Momordicae, Semen Strychni are fried to yellowish-brown with pot; mix with Herba Scutellariae Barbatae, Herba Lobeliae Chinensis, Radix Et Rhizoma Rhei, Herba Hedyotidis Diffusae, the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Radix Notoginseng, Spina Gleditsiae, Semen Strychni, Herba Asari, Caulis wisteriae sinensis, Galla Chinensis; after adding 3 times of water gagings; boiled with vigorous fire, then burnt 3 hours with slow fire, add Myrrha after truce; be cooled to 40 degree, filter.Dried Alumen, Sal Ammoniacus, Os Draconis (forging), Gekko Swinhonis (referring to Gekko Swinhonis), Zaocys, Scolopendra, Concha Margaritifera, Cipangopaludina chinensis are mixed with above-mentioned gained medicinal liquid, add 2 times of water gagings and fried in shallow oil 3 hours, filter.Filtering residue adds 4 times of water gagings to be fried in shallow oil 2 hours, filtered.Twice filtrate merges, and places sedimentation more than 12 hours, gets supernatant and is evaporated to extractum below 60 ℃ and contains crude drug 2g/ml.Extractum is put in stainless steel disc, and vacuum drying (below 60 ℃) claims dried cream (extractum rate approximately 15%) to pulverize, and adds appropriate cane sugar powder, makes 40 order dissolved granulies and packing, every bag 10g.
Medicine of the present invention is pure Chinese medicine, and formula meets theory of Chinese medical science, through for many years facts have proved its have heat-clearing and toxic substances removing, strengthening the body resistance, assault fortified position except tumor, drag inner pus, hemostasis and pain-relieving, antiinflammatory dampness, except necrotic tissue and promoting muscle growing, kill eight large functions of cancerous cell.
For showing that medicine of the present invention is to the therapeutic effect of oral cavity cancer, skin cancer, the present invention is through the clinical observation of 1000 routine oral cavity cancer patients and 1000 routine skin cancer systems, observation period is 90 days, the recovery from illness tumor disappears and is produce effects, the tumor growth of not fully recovering is obstructed as effectively, and tumor growth is normally invalid.
Using method: each serving 1 bag, every bag 10g, taking after mixing it with water with the 150ml boiled water gets final product, and takes every day 2 times.Clinical test results sees Table one.
Table one: use medicine of the present invention to oral cavity cancer, skin cancer patient's observation of curative effect.
| Group | Case load | Produce effects (number of cases) | Effectively (number of cases) | Invalid (number of cases) | Total effective rate (%) |
| The oral cancer group | 1000 | 921 | 79 | 0 | 100 |
| The skin carcinoma group | 1000 | 918 | 82 | 0 | 100 |
As can be seen from Table I, medicine of the present invention is to 1000 routine oral cavity cancer patients, and obtaining significant curative effect has 921 examples, accounts for 92.1%; That takes a turn for the better has 79 examples, accounts for 7.9%; Total effective rate 100%.Medicine of the present invention is to 1000 routine skin cancer patients, and obtaining significant curative effect has 918 examples, accounts for 91.8%; That takes a turn for the better has 82 examples, accounts for 8.2%; Total effective rate 100%.
Claims (4)
1. pharmaceutical composition for the treatment of oral cancer, skin carcinoma, it is characterized in that: the active component by following weight portion forms: Semen Momordicae 180-220 part, Herba Scutellariae Barbatae 45-55 part, Herba Lobeliae Chinensis 45-55 part, Radix Et Rhizoma Rhei 90-110 part, Herba Hedyotidis Diffusae 45-55 part, Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 90-110 part, Radix Notoginseng 18-22 part, Spina Gleditsiae 27-33 part; Semen Strychni 90-110 part, Herba Asari 45-55 part, Caulis wisteriae sinensis 45-55 part, Myrrha 45-55 part, Galla Chinensis 90-110 part; Dried Alumen 45-55 part, Sal Ammoniacus 18-22 part, Os Draconis 27-33 part; Gekko Swinhonis 18-22 part, Zaocys 8-12 part, Scolopendra 27-33 part, Concha Margaritifera 18-22 part, Cipangopaludina chinensis 18-22 part.
2. the pharmaceutical composition for the treatment of oral cancer as claimed in claim 1, skin carcinoma, it is characterized in that: the active component by following weight portion forms: 200 parts of Semen Momordicaes, 50 parts of Herba Scutellariae Barbataes, 50 parts of Herba Lobeliae Chinensis, 100 parts of Radix Et Rhizoma Rhei, 50 parts of Herba Hedyotidis Diffusaes, 100 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 20 parts of Radix Notoginseng, 30 parts of Spina Gleditsiaes; 100 parts of Semen Strychni, 50 parts of Herba Asaris, 50 parts, Caulis wisteriae sinensis, 50 parts of Myrrhas, 100 parts of Galla Chinensiss; 50 parts of dried Alumens, 20 parts of Sal Ammoniacuss, 30 parts of Os Draconis; 20 parts of Gekko Swinhoniss, 10 parts of Zaocyss, 30 parts of Scolopendras, 20 parts of Concha Margaritiferas, 20 parts of Cipangopaludina chinensiss.
3. the pharmaceutical composition for the treatment of oral cancer as claimed in claim 1, skin carcinoma, it is characterized in that: the active component by following weight portion forms: 180 parts of Semen Momordicaes, 46 parts of Herba Scutellariae Barbataes, 45 parts of Herba Lobeliae Chinensis, 90 parts of Radix Et Rhizoma Rhei, 45 parts of Herba Hedyotidis Diffusaes, 91 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 18 parts of Radix Notoginseng, 27 parts of Spina Gleditsiaes; 90 parts of Semen Strychni, 45 parts of Herba Asaris, 45 parts, Caulis wisteriae sinensis, 45 parts of Myrrhas, 90 parts of Galla Chinensiss; 45 parts of dried Alumens, 18 parts of Sal Ammoniacuss, 27 parts of Os Draconis; 18 parts of Gekko Swinhoniss, 8 parts of Zaocyss, 27 parts of Scolopendras, 18 parts of Concha Margaritiferas, 18 parts of Cipangopaludina chinensiss.
4. the pharmaceutical composition for the treatment of oral cancer as claimed in claim 1, skin carcinoma, it is characterized in that: the active component by following weight portion forms: 220 parts of Semen Momordicaes, 54 parts of Herba Scutellariae Barbataes, 55 parts of Herba Lobeliae Chinensis, 110 parts of Radix Et Rhizoma Rhei, 54 parts of Herba Hedyotidis Diffusaes, 110 parts of the Radixs Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), 22 parts of Radix Notoginseng, 33 parts of Spina Gleditsiaes; 110 parts of Semen Strychni, 55 parts of Herba Asaris, 55 parts, Caulis wisteriae sinensis, 55 parts of Myrrhas, 110 parts of Galla Chinensiss; 55 parts of dried Alumens, 22 parts of Sal Ammoniacuss, 33 parts of Os Draconis; 22 parts of Gekko Swinhoniss, 12 parts of Zaocyss, 33 parts of Scolopendras, 22 parts of Concha Margaritiferas, 22 parts of Cipangopaludina chinensiss.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100882817A CN102138991B (en) | 2011-04-10 | 2011-04-10 | Pharmaceutical composition for treating oral cancer and skin cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011100882817A CN102138991B (en) | 2011-04-10 | 2011-04-10 | Pharmaceutical composition for treating oral cancer and skin cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102138991A CN102138991A (en) | 2011-08-03 |
| CN102138991B true CN102138991B (en) | 2013-06-05 |
Family
ID=44406933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011100882817A Active CN102138991B (en) | 2011-04-10 | 2011-04-10 | Pharmaceutical composition for treating oral cancer and skin cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102138991B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104208525A (en) * | 2013-05-31 | 2014-12-17 | 吴本汉 | Traditional Chinese medicine composition for treating skin cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1539455A (en) * | 2003-10-27 | 2004-10-27 | 李林龙 | Medical combination possessing effect for turning cancer off and rejuvenation |
| CN1265901C (en) * | 2001-04-25 | 2006-07-26 | Sms德马格股份公司 | Rolling mill base for rail like rolling material |
| CN101049484A (en) * | 2007-05-14 | 2007-10-10 | 郝来勤 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1265901A (en) * | 2000-01-26 | 2000-09-13 | 徐忠廷 | Traditional Chinese medicinal pill for anti-cancer |
-
2011
- 2011-04-10 CN CN2011100882817A patent/CN102138991B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1265901C (en) * | 2001-04-25 | 2006-07-26 | Sms德马格股份公司 | Rolling mill base for rail like rolling material |
| CN1539455A (en) * | 2003-10-27 | 2004-10-27 | 李林龙 | Medical combination possessing effect for turning cancer off and rejuvenation |
| CN101049484A (en) * | 2007-05-14 | 2007-10-10 | 郝来勤 | Strong effective Chinese traditional medicine for treating lung cancer and other various cancers |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102138991A (en) | 2011-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101632827B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN102488795B (en) | Medicine for treating radiation dermatitis after head neck radiotheraphy | |
| CN103006997B (en) | Medicine for treating post-craniotomy headache | |
| CN102138991B (en) | Pharmaceutical composition for treating oral cancer and skin cancer | |
| CN102908423B (en) | Traditional Chinese medicine composition for treating stones | |
| CN105343660A (en) | Traditional Chinese medicinal preparation for treating peripheral vertigo and preparation method of traditional Chinese medicinal preparation | |
| CN102225118B (en) | Blood-activating wind-dispelling liquid | |
| CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
| CN101810831B (en) | Medicament for treating gynecological diseases | |
| CN101829188B (en) | Medicament for treating urinary infection and lithiasis | |
| CN101579507B (en) | Medicine for treating gall stones and preparation method thereof | |
| CN102283972B (en) | Pharmaceutical composition for treating rib fracture | |
| CN104645177A (en) | Traditional Chinese medicine composition for treating flat wart | |
| CN104324205A (en) | Traditional Chinese medicine composition for treating heart diseases | |
| CN103006995B (en) | Medicine for treating post-dural puncture headache (PDPHA) | |
| CN104127532B (en) | The application of a kind of NAOXINTONG JIAONANG in preparation treatment oncosis medicine | |
| CN103055051B (en) | Liquid for treating burn and scald | |
| CN102526385A (en) | Medicament for treating climacteric syndrome | |
| CN102114183A (en) | Medicament for treating hypertension | |
| CN103157082A (en) | Medicament for treating herpes zoster | |
| CN103239583B (en) | Airuike heart-soothing granule | |
| CN101554461A (en) | Medicine for treating psoriasis and preparation method of capsule thereof | |
| CN103550343A (en) | Lotion used for treating inflammations of reproduction system | |
| CN105560431A (en) | Traditional Chinese medicine for treating typhoid fever | |
| CN105106752A (en) | Acne removing drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: CUI HEFANG Free format text: FORMER OWNER: WANG XINGLI Effective date: 20140819 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276708 LINYI, SHANDONG PROVINCE TO: 266200 QINGDAO, SHANDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140819 Address after: 266200 Jimo, Shandong, the Yellow River Road No. two, No. 182, No. Patentee after: Cui Hefang Address before: 276708 Shandong city of Linyi province Linshu County Zhu Cang Xiang East Village Patentee before: Wang Xingli |
|
| ASS | Succession or assignment of patent right |
Owner name: RUDONG COUNTY CHAHE SEWAGE TREATMENT CO., LTD. Free format text: FORMER OWNER: CUI HEFANG Effective date: 20141225 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 266200 QINGDAO, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141225 Address after: Rudong County, Jiangsu province 226400 Chahe town Nantong City Xing River Village six groups Patentee after: Rudong County Chahe sewage treatment Co. Ltd. Address before: 266200 Jimo, Shandong, the Yellow River Road No. two, No. 182, No. Patentee before: Cui Hefang |